We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Skinbiotherapeutics Plc | LSE:SBTX | London | Ordinary Share | GB00BF33H870 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.125 | 0.72% | 17.375 | 17.00 | 17.75 | 17.75 | 17.25 | 17.25 | 453,939 | 10:07:40 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 132k | -2.84M | -0.0125 | -13.90 | 39M |
Date | Subject | Author | Discuss |
---|---|---|---|
04/12/2024 19:25 | So 2 million paid above market value on GW Now i will have to guess the case for that. Forward looking financials. If anyone wants to argue that, show me the model inputs. Must be @SPecial. Remembering, it's a cash net sum total for the purchase - so you need to deal in forward op earnings. How many years to recoup the GW? | putinaire | |
04/12/2024 19:14 | Is TW back in-line now re calling them all strong buys again? I think he just has a yearly whinge for a week until his pay is aligned with the lemmings | putinaire | |
04/12/2024 19:08 | I think the Americans are going to enjoy reading the financials on the weekend | putinaire | |
04/12/2024 19:03 | Re point to the RNS data link it up to. | putinaire | |
04/12/2024 19:03 | Just going back over the past 12 months of RNS's . Can somebody detail for me, what that is attributed to | putinaire | |
04/12/2024 18:45 | HOld on. Im just going to talk to somebody that knows what they are doing. And we can look at some pretty pictures in the near future | putinaire | |
04/12/2024 18:40 | maybe the earnouts are considered goodwill, like, to the bank account. Fk sake, confused now | putinaire | |
04/12/2024 18:37 | Unless they did pay 2 million over the odds? who gets that? | putinaire | |
04/12/2024 18:36 | According to my model, they are missing a - easy mistake though | putinaire | |
04/12/2024 18:36 | Shouldnt the valuation model have either said -2 million, or just giggled? | putinaire | |
04/12/2024 18:35 | Paid a 2 million premium? | putinaire | |
04/12/2024 18:35 | ummmm what? | putinaire | |
04/12/2024 17:00 | Better tell the CEO to bring in his own coffee, or the cash raise will be early 2025 | putinaire | |
04/12/2024 16:59 | Operating loss £2.9m (2023: loss £3.0m) with increase in sales balancing the increase in headcount costs Always important to balance the books yearly | putinaire | |
04/12/2024 16:55 | Where do you start here? Blackrock would have ripped their eyes out, 15 seconds after release | putinaire | |
04/12/2024 16:53 | Turnover number looks great. translates to 4 millions losses per norm i guess | putinaire | |
04/12/2024 16:51 | Putinaire - 12 Nov 2024 - 12:27:55 - 20326 of 20620 SkinBioTherapeutics PLC - Multi $bn skin health opportunities. - SBTX It's always great 2 split financials into 2 halves 1. Actuals and performance horrendous 2. Footnotes and acquisitions amazing I's just tradition, YoY NO point breaking with that now .......... Might as well start with the notes | putinaire | |
04/12/2024 16:44 | Ummmm just as well the seller got loads off this morning. A lucky delay Let's focus on H2 2025. And see how much worse it gets | putinaire |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions